Alterity Therapeutics (ATHE) Total Liabilities (2015 - 2025)

Alterity Therapeutics has reported Total Liabilities for 11 years, with the latest figure at $1.7 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities fell 3.6% year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (down 3.6% YoY), and the FY2025 full-year result was $2.3 million, down 35.1% from the prior year.
• Total Liabilities for Q4 2025 stood at $1.7 million, down from $2.3 million in the prior quarter.
• The five-year high for Total Liabilities was $4.2 million in Q2 2022, with the low at -$6.3 million in Q2 2024.
• Average Total Liabilities over 5 years is $1.5 million, with a median of $2.4 million recorded in 2021.
• Year-over-year, Total Liabilities plunged 13981.18% in 2024 and surged 137.11% in 2025.
• Tracing ATHE's Total Liabilities over 5 years: stood at $2.8 million in 2021, then grew by 25.23% to $3.5 million in 2022, then decreased by 14.24% to $3.0 million in 2023, then plunged by 39.3% to $1.8 million in 2024, then slipped by 3.6% to $1.7 million in 2025.
• The last three Total Liabilities figures came in at $1.7 million (Q4 2025), $2.3 million (Q2 2025), and $1.8 million (Q4 2024), per Business Quant data.

Peer Comparison